Prevest Denpro Share Price
380.00-9.70 (-2.49%)
-34.70% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | - | - | 14% |
| - | - | - | 13% |
| - | - | -7% | -33% |
| 18% | 18% | 18% | 18% |
Peer Comparison
Symbol
POLYMED-A
NURECA-T
PREVEST-M
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,702.25 | ₹17930 Cr | 56.91 | 8.49 | 43.73 | ₹322 Cr |
| 325 | ₹319 Cr | 73.48 | 3.21 | 6.74 | ₹2 Cr |
| 380 | ₹468 Cr | 21.53 | 4.7 | 19.8 | ₹20 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
PBT
Net Profit
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹19 Cr | ₹19 Cr | ₹18 Cr | ₹19 Cr | ₹16 Cr | ₹18 Cr | ₹15 Cr | ₹16 Cr | ₹13 Cr | ₹16 Cr | ₹14 Cr | ₹13 Cr | ₹13 Cr |
| ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹86 L | ₹84 L | ₹68 L | ₹74 L | ₹61 L |
| ₹20 Cr | ₹20 Cr | ₹20 Cr | ₹20 Cr | ₹17 Cr | ₹20 Cr | ₹16 Cr | ₹17 Cr | ₹14 Cr | ₹17 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr |
| ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹12 Cr | ₹11 Cr | ₹12 Cr | ₹10 Cr | ₹11 Cr | ₹9 Cr | ₹11 Cr | ₹10 Cr | ₹9 Cr | ₹9 Cr |
| ₹8 Cr | ₹8 Cr | ₹7 Cr | ₹8 Cr | ₹6 Cr | ₹8 Cr | ₹6 Cr | ₹7 Cr | ₹5 Cr | ₹7 Cr | ₹5 Cr | ₹5 Cr | ₹6 Cr |
| ₹8 Cr | ₹8 Cr | ₹6 Cr | ₹7 Cr | ₹6 Cr | ₹7 Cr | ₹6 Cr | ₹6 Cr | ₹5 Cr | ₹6 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr |
| ₹6 Cr | ₹6 Cr | ₹5 Cr | ₹6 Cr | ₹4 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹4 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Deferred Tax Assets / Liabilities
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Provisions
Total Current Liabilities
Total Liabilities
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 |
|---|---|---|
| — | — | — |
| ₹12 Cr | ₹12 Cr | ₹12 Cr |
| ₹113 Cr | ₹94 Cr | ₹77 Cr |
| ₹113 Cr | ₹94 Cr | ₹77 Cr |
| ₹125 Cr | ₹106 Cr | ₹89 Cr |
| ₹1 Cr | ₹100 L | ₹69 L |
| ₹1 Cr | ₹100 L | ₹69 L |
| — | — | — |
| ₹2 Cr | ₹2 Cr | ₹1 Cr |
| ₹4 Cr | ₹4 Cr | ₹4 Cr |
| ₹34 L | ₹9 L | ₹35 L |
| ₹7 Cr | ₹6 Cr | ₹6 Cr |
| ₹133 Cr | ₹113 Cr | ₹95 Cr |
| — | — | — |
| ₹37 Cr | ₹35 Cr | ₹33 Cr |
| ₹10 Cr | ₹8 Cr | ₹6 Cr |
| ₹27 Cr | ₹27 Cr | ₹27 Cr |
| ₹27 Cr | ₹27 Cr | ₹27 Cr |
| — | — | — |
| ₹9 Cr | ₹5 Cr | ₹2 Cr |
| ₹11 Cr | ₹8 Cr | ₹6 Cr |
| ₹9 Cr | ₹8 Cr | ₹8 Cr |
| ₹73 Cr | ₹61 Cr | ₹49 Cr |
| ₹92 L | ₹1 Cr | ₹8 L |
| ₹4 Cr | ₹3 Cr | ₹3 Cr |
| ₹106 Cr | ₹86 Cr | ₹68 Cr |
| ₹99 Cr | ₹80 Cr | ₹63 Cr |
| ₹133 Cr | ₹113 Cr | ₹95 Cr |
| ₹104 | ₹88 | ₹74 |
| ₹104 | ₹88 | ₹74 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Effect of Foreign Exchange Fluctuations
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 |
|---|---|---|
| ₹28 Cr | ₹24 Cr | ₹21 Cr |
| -₹2 Cr | -₹2 Cr | -₹1 Cr |
| -₹4 Cr | -₹2 Cr | -₹4 Cr |
| ₹21 Cr | ₹21 Cr | ₹16 Cr |
| ₹15 Cr | ₹15 Cr | ₹12 Cr |
| -₹2 Cr | -₹1 Cr | -₹2 Cr |
| -₹1 Cr | -₹1 Cr | -₹32 L |
| ₹12 Cr | ₹12 Cr | ₹10 Cr |
| ₹61 Cr | ₹49 Cr | ₹39 Cr |
| -₹6 L | ₹0 | ₹0 |
| ₹73 Cr | ₹61 Cr | ₹49 Cr |
Fundamental Ratios
Consolidated
Standalone
No results found